OConnor JC, Lawson MA, Andr C, Moreau M, Lestage J, Castanon N, et al
Retrieved from Varughese, M
For this study, we used Google Search Trends to determine GLP-1-related searches and increases in searches over the last year in the 100 most populous U.S
Animal studies have also identified a potential risk of thyroid C-cell tumors, which is why these medications are not recommended for patients with a personal or family history of specific thyroid cancers
This is different from pharmaceutical GLP-1 receptor agonists used in medical treatments
El ensayo OASIS 1, en personas con obesidad y sobrepeso sin DM2, evidenci que la SEMA oral a 50 mg logr una prdida media del 15,1% del peso corporal frente al 2,4% con placebo en 68 semanas, aunque con una incidencia relevante de efectos gastrointestinales y disestesias en el 13% de participantes, lo que ha impulsado el estudio de dosis intermedias para optimizar eficacia y tolerabilidad